SouthState Corp’s Zomedica Corp. ZOM Stock Holding History

SouthState Corp’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,750	Closed	-$460	–	706
2023 Q3	$460	Buy	+2,750	New	+$534	﹤0.01%	613

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SouthState Corp's ZOM Position: Q4 2023 in Review

SouthState Corp sold out of Zomedica Corp. (ZOM) in Q4 2023, closing a stake of 2,750 shares — an estimated $460 sold.

SouthState Corp first reported a position in ZOM in Q3 2023 and held it in 1 quarter. The position peaked at $460 in Q3 2023. 92 funds tracked by Wall St. Rank hold ZOM as of Q4 2023.

SouthState Corp reported no remaining Zomedica Corp. position as of Q4 2023 after selling out during the quarter.
SouthState Corp sold 2,750 Zomedica Corp. shares in Q4 2023, an estimated $460.
SouthState Corp first reported a position in Zomedica Corp. in Q3 2023 and held it in 1 quarter.
SouthState Corp's Zomedica Corp. position peaked at $460 in Q3 2023.
92 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2023.

Based on SouthState Corp's 13F filing for Q4 2023, filed 6 Feb 2024.